Evidence map›Paper›PMID 40042287›Full record

ArticleMicrobiology spectrum2025

Resistome and virulome determination in

Léo Gillet, Lucie Bénéjat, Quentin Jehanne, Pierre-Louis Maunet, Claudie Perreau, Astrid Ducournau, Johanna Aptel, Marine Jauvain, Philippe Lehours

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Assessment ofMicroorganisms · 2026
    Article
  2. Article
  3. Enrichment techniques for clinical metagenomics.Frontiers in cellular and infection microbiology · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Léo GilletCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.ORCID 0009-0008-8854-6732
Lucie BénéjatCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Quentin JehanneCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Pierre-Louis MaunetCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Claudie PerreauCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Astrid DucournauCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Johanna AptelCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Marine JauvainCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Philippe LehoursCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.ORCID 0000-0001-6077-1825

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of

Indexed as

Drug Resistance, BacterialHelicobacter InfectionsHelicobacter pyloriHigh-Throughput Nucleotide SequencingAnti-Bacterial AgentsBacterial ProteinsBiopsyDNA, BacterialDNA GyraseHumansMultilocus Sequence TypingPhylogenyRNA, Ribosomal, 23SVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsDNA, BacterialDNA GyraseRNA, Ribosomal, 23SVirulence Factorsgastric biopsyH. pylorinext-generation sequencingresistometarget-enrichment

Identifiers

PMID40042287
PMCPMC11960115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.